EARLIER THIS MONTH, Focus Technologies reference laboratories of Cypress, California announced the development of a “first-generation, real-time PCR test” designed to detect the presence of the coronavirus associated with severe acute respiratory syndrome (SARS).
“Focus developed this test based on the methodology developed by the Bernhard-Nocht Institute of Hamburg, Germany,” stated Mary Kay Mosch, Vice President of
SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME
IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last year.
Notwithstanding these rumors, the reality at Specialty Labs is quite different. On April 24, the company, based in Santa
CEO SUMMARY: Diagnostic manufacturers will begin to face the same controversy over public access to diagnostic testing technology that has dogged pharmaceutical companies in recent years. Public health officials and the military are unhappy with how Bio-Rad and its HIV-2 licensees have failed to provide the United States with a rapid HIV-2 test.
EXPECT MORE CONTROVERSY
CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he calls the “diagnostic services industry.” He is bullish on the future